1. Hims & Hers' acquisition of ZAVA accelerates its expansion into Europe's weight-loss market, boosting subscribers by 54%; 2. The deal is cost-effective, leveraging ZAVA's infrastructure and regulatory expertise in key European markets; 3. The company's proven U.S. GLP-1 strategy positions it to meet Europe's demand for affordable telehealth weight-loss solutions, with strong growth and undervalued stock making it a buy.